These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 1708772)
1. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). Page JD; Colman RW J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772 [TBL] [Abstract][Full Text] [Related]
2. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4. Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705 [TBL] [Abstract][Full Text] [Related]
3. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain. Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159 [TBL] [Abstract][Full Text] [Related]
4. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface. Veloso D; Silver LD; Hahn S; Colman RW Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201 [TBL] [Abstract][Full Text] [Related]
5. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. Hock J; Vogel R; Linke RP; Müller-Esterl W J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Reddigari SR; Kaplan AP Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143 [TBL] [Abstract][Full Text] [Related]
7. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein. Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861 [TBL] [Abstract][Full Text] [Related]
8. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. Joseph K; Tholanikunnel BG; Kaplan AP J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Kaplan AP; Joseph K Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213 [TBL] [Abstract][Full Text] [Related]
10. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization. Shimada T; Kato H; Maeda H; Iwanaga S J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613 [TBL] [Abstract][Full Text] [Related]
11. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. Tayeh MA; Olson ST; Shore JD J Biol Chem; 1994 Jun; 269(23):16318-25. PubMed ID: 8206938 [TBL] [Abstract][Full Text] [Related]
12. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain. Page JD; You JL; Harris RB; Colman RW Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388 [TBL] [Abstract][Full Text] [Related]
13. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein. Johansen HT; Briseid K Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Nakazawa Y; Joseph K; Kaplan AP Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915 [TBL] [Abstract][Full Text] [Related]
15. The bradykinin-forming cascade: a historical perspective. Kaplan AP Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400 [TBL] [Abstract][Full Text] [Related]
16. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites. Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593 [TBL] [Abstract][Full Text] [Related]
17. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2. Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801 [TBL] [Abstract][Full Text] [Related]
18. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780 [TBL] [Abstract][Full Text] [Related]
19. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation. Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197 [TBL] [Abstract][Full Text] [Related]
20. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]